Innate Pharma S.A. (EPA:IPH)
1.304
-0.044 (-3.26%)
Oct 22, 2026, 5:35 PM CEST
Innate Pharma Employees
Innate Pharma had 120 employees as of June 30, 2026. The number of employees decreased by 44 or 26.83% since the number was reported on December 31, 2025. That makes Innate Pharma the 30,374th largest employer in the world and 381st in France.
Employees
120
Change
-44
Growth
-26.83%
Revenue / Employee
€81,733
Profits / Employee
€395,467
Market Cap
122.19M
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 120 | -44 | -26.83% |
| Dec 31, 2025 | 164 | -17 | -9.39% |
| Dec 31, 2024 | 181 | 2 | 1.12% |
| Dec 31, 2023 | 179 | -32 | -15.17% |
| Dec 31, 2022 | 211 | -4 | -1.86% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 620 |
| Cellectis | 229 |
| Genfit | 180 |
| Transgene | 152 |
| Adocia | 80 |
| Sensorion | 66 |
| OSE Immunotherapeutics | 64 |
| Fermentalg | 64 |
Innate Pharma News
- 2 days ago - Innate Pharma SA: Innate Pharma to Participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference - Finanz Nachrichten
- 2 days ago - Innate Pharma to Participate in the Stifel Healthcare Conference and Jefferies Global Healthcare Conference - Business Wire
- 3 days ago - Innate Pharma SA: Innate Pharma Announces Conference Call for Third Quarter 2026 Business and Financial Update - Finanz Nachrichten
- 3 days ago - Innate Pharma Announces Conference Call for Third Quarter 2026 Business and Financial Update - Business Wire
- 14 days ago - Down 22% in 4 Weeks, Here's Why Innate Pharma (IPHA) Looks Ripe for a Turnaround - Nasdaq
- 17 days ago - Down 25% in 4 Weeks, Here's Why You Should You Buy the Dip in Innate Pharma (IPHA) - Nasdaq
- 20 days ago - Innate Pharma S.A. - Depositary Receipt Price Target Increased by 27.91% to $8.22 - Nasdaq
- 5 weeks ago - Innate Pharma (IPHA) Q2 2026 Earnings Call Transcript - The Motley Fool